SCHEMBL19921

SCHEMBL19921

Fc1cc[c]cc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27592615 0.97
SCHEMBL27513290 0.97
SCHEMBL19667230 0.91
SCHEMBL28382051 0.91
SCHEMBL118251 0.79
SCHEMBL27654068 0.77
SCHEMBL57893 0.75
SCHEMBL43352 0.75
Water SCHEMBL8015768 0.75
SCHEMBL1135190 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11283 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120442-A1 PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 WO claimed
US-20240182462-A1 FLUOROALKYL-OXADIAZOLES AND USES THEREOF TENAYA THERAPEUTICS, INC. 2024-06-06 US claimed
US-20240174603-A1 MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME RAPPTA THERAPEUTICS OY (FI) 2024-05-30 US claimed
WO-2024104384-A1 INDENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS NUCMITO PHARMACEUTICALS CO. LTD. (CN) 2024-05-23 WO claimed
WO-2024102177-A1 COMBINATION THERAPIES FOR THE TREATMENT OF BRAIN CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-05-16 WO claimed
EP-4362949-A2 USE OF ISOQUINOLINE-1,5-DIAMINES FOR WOUND HEALING Lutris Pharma Ltd. (IL) 2024-05-08 EP claimed
US-20240122933-A1 USE OF ISOQUINOLINE-1,5-DIAMINES FOR WOUND HEALING LUTRIS PHARMA LTD (IL) 2024-04-18 US claimed
WO-2024081447-A1 EGFR INHIBITORS FOR TREATING LUNG CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-04-18 WO claimed
WO-2024081927-A1 COMPOUNDS FOR IMPROVEMENT OF VIRAL PRODUCTION TENAYA THERAPEUTICS, INC. (US) 2024-04-18 WO claimed
EP-3893645-B1 SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (CA) 2024-04-17 EP claimed
US-4716168-A STIMULANTS OF IMMUNE RESPONSE NORWICH EATON PHARMACEUTICALS, INC. (US) 1987-12-29 US claimed
EP-0236618-A2 Insecticidal N'-substituted-N,N'-diacylhydrazines ROHM AND HAAS COMPANY (US) 1987-09-16 EP claimed
EP-0187705-A2 Imidazo(4,5-f)quinolines useful as immunomodulating agents Norwich Eaton Pharmaceuticals, Inc. (US) 1986-07-16 EP claimed
EP-0154528-A2 Alkene, alkyne or cycloalkylene derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-09-11 EP claimed
EP-0012822-B1 3,4-DISUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINES, THEIR ACID ADDITION SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR THEIR PRODUCTION C.H. BOEHRINGER SOHN (DE) 1982-12-01 EP claimed
EP-0017976-A2 Process for preparing imidazole derivatives F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-10-29 EP claimed
EP-0012822-A1 3,4-Disubstituted 2-phenylimino-imidazolidines, their acid addition salts, pharmaceutical preparations containing them and process for their production C.H. BOEHRINGER SOHN (DE) 1980-07-09 EP claimed
US-4197403-A ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE, FUNGICIDE WESTWOOD PHARMACEUTICALS INC. (US) 1980-04-08 US claimed
US-3973010-A Insecticidal and acaricidal composition and method with triazolyl phosphoric esters acid CIBA-GEIGY CORPORATION (US) 1976-08-03 US claimed
US-3950538-A Anti-inflammatory methods utilizing certain thioureas THE DOW CHEMICAL COMPANY (US) 1976-04-13 US claimed